Expanded Newborn Screening: Outcome in Screened and Unscreened Patients at Age 6 Years

Bridget Wilcken; Marion Haas; Pamela Joy; Veronica Wiley; Francis Bowling; Kevin Carpenter; John Christodoulou; David Cowley; Carolyn Ellaway; Janice M. Fletcher; Edwin P. Kirk; Barry Lewis; Jim McGill; Heidi Peters; James Pitt; Enzo Ranieri; Joy Yaplito‐Lee; Avihu Boneh

doi:10.1542/peds.2008-0586

Abstract

This is the authors' abstract. We don't add key points for this paper.

Screening by tandem mass spectrometry provides a better outcome for patients at 6 years of age, with fewer deaths and fewer clinically significant disabilities.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wilcken et al. (2009) studied this question.

synapsesocial.com/papers/69daca9a7a67537a8ba3c84b https://doi.org/10.1542/peds.2008-0586

View at Publisher

Ask AI

Bookmark

Share

Expanded Newborn Screening: Outcome in Screened and Unscreened Patients at Age 6 Years

Abstract

Ask about this paper

Discussion

Cite This Study

Expanded Newborn Screening: Outcome in Screened and Unscreened Patients at Age 6 Years

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading